Skip to content

Camden National CAC Termination value

Termination value at other companies

Chart Industries logo
Chart IndustriesGTLS
$66.5M
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$110K
Boston Beer logo
Boston BeerSAM
$5M0.0%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$16.25M
Chart Industries logo
Chart IndustriesGTLS
$258M
Rocket Lab USA, Inc. logo
Rocket Lab USA, Inc.RKLB
$0

Other financials

Income statement

See full
Revenue$64.3M+7.1%
Net income$21.9M+199%
EPS (diluted)$1.29+200%

Balance sheet

See full
Cash & equivalents$133.7M-39.0%
Total debt$514.3M-9.4%
Total equity$710.0M+10.9%
Total assets$7.0B0.0%

Cash flow

See full
Operating cash flow$20.0M+1,835%
CapEx$1.8M+0.9%
Free cash flow$18.2M+2,608%

Valuation

See full
Market cap$898.68M+37.9%
Enterprise value$1.28B+27.9%
P/E11.3×-2.6×
P/S3.5×+0.1×

Profitability

See full
Net margin30.7%+6.6pp
FCF margin29.7%

Returns & leverage

See full
Return on equity11.8%+3.6pp
Debt / equity0.7×-0.2×

Where this comes from

Reported directly by Camden National in its filing.

Tagged under the XBRL concept cac:ProvisionBreachSettlementObligationTerminationValue.

The official record: Camden National’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Camden National's termination value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Camden National's termination value?
Camden National (CAC) reported termination value of $8M in Q1 2026.
How has Camden National's termination value changed year-over-year?
Camden National's termination value increased by 185.7% year-over-year, from $2.8M to $8M.
What is the long-term trend for Camden National's termination value?
Over 5 years (2020 to 2025), Camden National's termination value has grown at a -31.7% compound annual growth rate (CAGR), from $50.5M to $7.5M.
What does termination value mean?
This represents the estimated financial obligation required to settle or terminate contracts in the event of a breach or early exit. It serves as a measure of potential exit costs and the financial exposure associated with contractual non-performance or restructuring.